Kati Räisänen
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 10
-
- Antibiotic Use and Resistance 3
- Endocrinology top 10%
- Enterobacteriaceae and Cronobacter Research 3
- Vibrio bacteria research studies 3
- Infections and bacterial resistance 2
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing 4
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 3
-
- Streptococcal Infections and Treatments 2
Kati Räisänen
12 papers receiving 361 citations
Peers
Comparison fields: 5 of 51
- Molecular Medicine 122
- Applied Microbiology and Biotechnology 33
- Endocrinology 62
- Clinical Biochemistry 60
- Infectious Diseases 152
Countries citing papers authored by Kati Räisänen
This map shows the geographic impact of Kati Räisänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Räisänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Räisänen more than expected).
Fields of papers citing papers by Kati Räisänen
This network shows the impact of papers produced by Kati Räisänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Räisänen. The network helps show where Kati Räisänen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kati Räisänen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 25 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 9 | |
| 5 | 2021 | 14 | |
| 6 | Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20 | 2021 | 1 |
| 7 | 2020 | 1 | |
| 8 | 2020 | 18 | |
| 9 | 2019 | 19 | |
| 10 | 2019 | 52 | |
| 11 | 2019 | 18 | |
| 12 | 2017 | 3 | |
| 13 | Bakteerien mikrobilääkeresistenssi Suomessa : Finres 2016 | 2017 | 0 |
| 14 | 2014 | 197 |
About Kati Räisänen
Kati Räisänen is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 14 papers that have together received 367 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (4 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Vibrio bacteria research studies (3 papers), Antibiotic Use and Resistance (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Streptococcal Infections and Treatments (2 papers) and Infections and bacterial resistance (2 papers). The work is most often cited by research in Molecular Medicine (122 citations), Applied Microbiology and Biotechnology (33 citations) and Endocrinology (62 citations). Kati Räisänen has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Jari Jalava, Outi Lyytikäinen, Jaana Vuopio, Dominique A. Caugant, Chris Van Beneden, Stephen B. Beres, Donald E. Low, Magnús Gottfreðsson, Steen Hoffmann and Karl G. Kristinsson.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.